Stocks TelegraphStocks Telegraph
Stock Ideas

VKTX Stock Performance and Key Statistics

NASDAQ : VKTX

Viking Therapeutics

$32.37
1.99+6.55%
At Close 4:00 PM
55.83
B-ESG ScoreESG Rating

stock performance chart

VKTX Fundamental Analysis

Based on recent data, Viking Therapeutics, Inc. (VKTX) shows an Average True Range (ATR) of 2.04 and an Enterprise Value of 7.06B. Its average trading volume over the past 3 months is 2.17M, indicating liquidity. These fundamental metrics provide insight into VKTX's underlying financial health and market activity.

ATR2.04
Enterprise Value7.06B
Avg Vol (3 Months)2.17M
Avg Vol (10 Days)2.48M

VKTX Technical Analysis Indicators

Viking Therapeutics, Inc. (VKTX) technical indicators as of June 23, 2026: the SMA 20 is 8.81%, SMA 50 at 1.77%, and SMA 200 at 4.75%. The RSI 14 value is 55.58, suggesting its current momentum. These technical analysis signals help assess VKTX's price trends and potential future movements.

SMA 208.81%
SMA 501.77%
SMA 2004.75%
RSI 1455.58

VKTX Stock Performance Overview

Viking Therapeutics, Inc. (VKTX) stock performance overview as of June 23, 2026: The 52-week high is $43.15 (currently -23.59% below), and the 52-week low is $22.96 (currently 74.26% above). Over the past year, VKTX's performance is 2.95%, compared to the S&P 500's 10.67% change.

52-Week High43.15
52-Week High Chg-23.59%
52-Week Low22.96
52-Week Low Chg+74.26%
S&P 500 52-Week Chg10.67%

Viking Therapeutics, Inc. (VKTX) Historical Stock Performance

According to market data, Viking Therapeutics, Inc. (VKTX) stock's recent performance metrics show that over the last month, VKTX is -2.27%, with a Year-to-Date (YTD) performance of -4.72%. Over the past year, the stock has seen a 2.95% change. These figures summarize VKTX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High32.933.1636.6339.0843.1537.5
Low2927.1627.1625.7722.9625.77
Performance+5.54%-2.27%-0.04%+4.95%+2.95%-4.72%

Industry Analysis and Valuation

According to current financial data, VKTX stock's P/E (TTM) ratio is -7.73, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for VKTX, including P/S (N/A), P/B (7.37), and P/FCF (-10.92), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationVKTXSector MedianIndustry AvgS&P 500
P/E (TTM)-7.73-1.22-5.0232.59
P/S (TTM)N/A3.69462.045.98
P/B (TTM)7.370.0212.185
P/FCF (TTM)-10.92-11.37-908.5628.32

Frequently Asked Questions

How is VKTX price-to-earnings ratio currently?
VKTX has a current P/E ratio of -7.73
How are VKTX's price-to-sale and price-to-book ratios?
The VKTX stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 7.37.
Is Viking Therapeutics, Inc.'s price-to-cashflow ratio high or low?
VKTX's price-to-free-cashflow (P/FCF) ratio is -10.92, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for VKTX?
Based on VKTX's recent bid, its distance from 20 days simple moving average is 8.81%. It is 1.77% apart from 50 days simple moving average, and it is 4.75% apart from 200 days simple moving average.
What is the 52-week price range for VKTX?
The 52-week high for VKTX is $43.15 which is -23.59% away from the current price level whereas the distance of that from the 52-week low of $22.96 stands at 74.26%.
An overview of VKTX's stock performance: how did it fare?
The performance of VKTX stock was not encouraging with most of its significant price indicators in red. Viking Therapeutics, Inc.(NASDAQ: VKTX) shares have moved upward +6.55% or $1.99 in the latest trading session and have lost -4.72% year-to-date (YTD). The stock has gained nearly 2.95% over the past year. After moving -0.04% over the trailing 3-month period, the stock is 4.95% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 5.54% a week and -2.27% a month.
What is VKTX's 14-day relative strength index (RSI)?
The current 14-day RSI for VKTX stock is 55.58. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For VKTX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Viking Therapeutics, Inc. (VKTX) has a 14-day ATR of 2.04.
What is VKTX's current enterprise value?
After closing at $30.38 with 116.11M of its shares outstanding, the current enterprise value of VKTX is roughly 7.06B.
Over the past year, how has the stock price of VKTX changed?
Viking Therapeutics, Inc. (NASDAQ: VKTX) is up 2.95% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 10.67%. VKTX stock price is also down -4.72% on its value in year-to-date trading.
What is the average trading volume for VKTX shares?
The number outstanding shares of VKTX is 116.11M, and of these 97.02% shares are freely available for trading. On average, VKTX stock has traded 2.48M shares per day for the past 10 days. A total of 3.25M shares changed hands during the last trading session with the average session volume of 2.18M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph